undefined undefined
NaN.000
NaN.00%
Cel-Sci press release (NYSE:CVM): Q2 GAAP EPS of -$0.28 misses by $0.15. More on Cel-Sci CEL-SCI gains as FDA greenlights confirmatory study for Multikine Seeking Alpha’s Quant Rating on Cel-Sci Histo...
05-16 21:27
CEL-SCI Corporation (NYSE:CVM) traded higher on Wednesday after the company said that the U.S. Food and Drug Administration (FDA) cleared its plans to conduct a confirmatory study for its lead asset, ...
05-08 21:33
Cel-Sci Corp. (CVM) has shared an announcement. CEL-SCI Corporation has enhance...
04-24 05:12
CEL-SCI Clocks FY23 EPS Loss of $(0.73) Vs $(0.87) YoY, Operating Loss of $(31....
2023-12-22 09:04
美债收益率抬头压制美股,周一特斯拉、苹果、英伟达期权成交量大幅下滑;猫途鹰绩后再升2.29%,获大单押注其股价反弹趋势延续>>
2023-11-07 14:32
CEL-SCI Corporation (NYSE:CVM) today released a letter to shareholders from the Company's CEO, Geert Kersten. The very comprehensive letter details the data reported on the efficacy of Multikine (Leukocyte Interleukin,
2023-10-30 21:20
During Monday's session, 201 stocks hit new 52-week lows.
2023-08-15 01:48
CEL-SCI Corporation (NASDAQ: CVM) shares are trading lower by 21.3% to $2.25 Tuesday morning after the company priced its public offering of 2.5 million shares at $2.00 per share.
2023-07-18 23:07
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to 14,190.20. The S&P 500, also fell, declining, 0.05% to 4,520.47.
2023-07-18 21:51
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares increased by 89.5% to $0.5...
2023-07-18 05:32